Daiwa Securities Group Inc. reduced its stake in shares of HCP, Inc. (NYSE:HCP) by 75.5% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,996,035 shares of the real estate investment trust’s stock after selling 9,247,006 shares during the period. Daiwa Securities Group Inc.’s holdings in HCP were worth $78,136,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Advisory Services Network LLC lifted its position in shares of HCP by 4.1% during the 2nd quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock valued at $121,000 after buying an additional 150 shares in the last quarter. Fieldpoint Private Securities LLC purchased a new position in shares of HCP during the 3rd quarter valued at about $147,000. Penserra Capital Management LLC purchased a new position in shares of HCP during the 3rd quarter valued at about $163,000. Koch Industries Inc. purchased a new position in shares of HCP during the 2nd quarter valued at about $208,000. Finally, Cetera Investment Advisers purchased a new position in shares of HCP during the 2nd quarter valued at about $208,000. 90.97% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HCP, Inc. (NYSE:HCP) opened at $22.70 on Friday. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.17. HCP, Inc. has a 12 month low of $22.63 and a 12 month high of $33.67. The stock has a market capitalization of $10,967.75, a P/E ratio of 20.40, a price-to-earnings-growth ratio of 4.23 and a beta of 0.27.
A number of research analysts have recently weighed in on HCP shares. Mizuho raised HCP from a “neutral” rating to a “buy” rating and set a $32.00 price objective on the stock in a research report on Thursday, November 2nd. Stifel Nicolaus raised HCP from a “hold” rating to a “buy” rating and set a $29.00 target price on the stock in a research note on Tuesday, December 5th. Morgan Stanley reissued an “equal weight” rating and set a $29.00 target price on shares of HCP in a research note on Thursday, December 14th. ValuEngine downgraded HCP from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Zacks Investment Research raised HCP from a “sell” rating to a “hold” rating in a research note on Thursday, November 9th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $30.14.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://sportsperspectives.com/2018/02/09/daiwa-securities-group-inc-has-78-14-million-stake-in-hcp-inc-hcp.html.
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.